Mani Foroohar

Stock Analyst at Leerink Partners

(1.47)
# 3,157
Out of 4,765 analysts
182
Total ratings
41.18%
Success rate
-14.38%
Average return

Stocks Rated by Mani Foroohar

Recursion Pharmaceuticals
Feb 28, 2025
Maintains: Market Perform
Price Target: $7$6
Current: $6.17
Upside: -2.76%
4D Molecular Therapeutics
Jan 13, 2025
Maintains: Outperform
Price Target: $31$27
Current: $4.24
Upside: +536.79%
Rocket Pharmaceuticals
Nov 19, 2024
Maintains: Outperform
Price Target: $46$44
Current: $8.70
Upside: +406.04%
Lexeo Therapeutics
Nov 13, 2024
Maintains: Outperform
Price Target: $20$19
Current: $2.91
Upside: +552.92%
Neurogene
Nov 12, 2024
Maintains: Outperform
Price Target: $45$72
Current: $17.78
Upside: +304.95%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: $17
Current: $5.28
Upside: +221.97%
Mirum Pharmaceuticals
Oct 17, 2024
Maintains: Outperform
Price Target: $47$49
Current: $45.03
Upside: +8.82%
BridgeBio Pharma
Oct 17, 2024
Maintains: Outperform
Price Target: $47$46
Current: $32.59
Upside: +41.15%
Wave Life Sciences
Oct 16, 2024
Maintains: Outperform
Price Target: $20$22
Current: $10.81
Upside: +103.52%
Ionis Pharmaceuticals
Jul 24, 2024
Upgrades: Outperform
Price Target: $53$62
Current: $33.41
Upside: +85.57%
Initiates: Outperform
Price Target: $13
Current: $14.49
Upside: -10.28%
Initiates: Outperform
Price Target: $29
Current: $22.77
Upside: +27.36%
Maintains: Outperform
Price Target: $165$230
Current: $99.65
Upside: +130.81%
Downgrades: Market Perform
Price Target: $12$4
Current: $3.16
Upside: +26.58%
Upgrades: Outperform
Price Target: n/a
Current: $6.65
Upside: -
Initiates: Outperform
Price Target: $31
Current: $5.29
Upside: +486.01%
Downgrades: Market Perform
Price Target: $23
Current: $9.67
Upside: +137.85%
Initiates: Outperform
Price Target: $7
Current: $0.62
Upside: +1,028.12%
Downgrades: Market Perform
Price Target: $40
Current: $15.77
Upside: +153.65%
Downgrades: Underperform
Price Target: $111$93
Current: $36.43
Upside: +155.32%
Maintains: Outperform
Price Target: $86$84
Current: $9.62
Upside: +773.18%
Maintains: Market Perform
Price Target: $6$7
Current: $1.50
Upside: +366.67%
Maintains: Market Perform
Price Target: $180$160
Current: $3.82
Upside: +4,088.48%
Maintains: Outperform
Price Target: $81$77
Current: $27.48
Upside: +180.20%
Maintains: Market Perform
Price Target: $144$143
Current: $240.96
Upside: -40.65%
Maintains: Market Perform
Price Target: $5$6
Current: $5.59
Upside: +7.33%
Maintains: Outperform
Price Target: $75$76
Current: $43.47
Upside: +74.83%
Maintains: Outperform
Price Target: $30$34
Current: $1.05
Upside: +3,138.10%
Maintains: Market Perform
Price Target: $50$20
Current: $4.83
Upside: +314.08%